James Lacamp serves as Executive at PETMED EXPRESS INC, where they oversee executive responsibilities. Since joining the company, James Lacamp has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 30, 2025 involved receiving (via award) 34,866 shares valued at $0.
James Lacamp currently holds 34,866 shares of PETMED EXPRESS INC (PETS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Lacamp has been a net neutral trader of PETS stock. They have purchased $0 and sold $0 worth of shares.
James Lacamp's most recent insider trade was on Oct 30, 2025, when they sold 34,866 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |